Text Size

Assessment of Spread of Transversus Abdominis Plane Block

This study has been completed.
Sponsor:
Collaborator:
Glostrup University Hospital, Copenhagen
Information provided by:
Herlev Hospital
ClinicalTrials.gov Identifier:
NCT01024868
First received: December 2, 2009
Last updated: May 3, 2010
Last verified: December 2009
History of Changes
  Purpose

For the purpose of assessing the spread of the local anaesthetic after injecting it between abdominal muscles on both sides, the investigators will test if the patient can feel a change in the perception of cold and warm, as well as being pricked with a blunt needle. The investigators will also take several blood samples, together with routine samples, to measure the concentration of the local anesthetic in the blood.


Condition Intervention
Transversus Abdominis Plane Block
 Drug: Ropivacaine 0,5%

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Assessment of Spread of Transversus Abdominis Plane Block After Administration of 20 ml Ropivacaine 0,5% Bilaterally

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Herlev Hospital:

Estimated Enrollment: 20
Study Start Date: December 2009
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
TAP block
Patients before undergoing laparoscopic or other abdominal surgery
 Drug: Ropivacaine 0,5%
Injection of ropivacaine 0,5% 20 ml bilaterally before surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing abdominal surgery

Criteria

Inclusion Criteria:

  • undergo abdominal surgery, eligible for TAP block, over 18, BMI 20-40

Exclusion Criteria:

  • does not speak danish, does not consent, does not fulfill inclusion criteria
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01024868

Locations
Denmark
Herlev University Hospital
Herlev, Denmark, 2730
Sponsors and Collaborators
Herlev Hospital
Glostrup University Hospital, Copenhagen
Investigators
Study Director: Ann M Møller, dr. med. Herlev Hospital
  More Information

No publications provided by Herlev Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Dr Anja U. Mitchell, Herlev University Hospital, Copenhagen
ClinicalTrials.gov Identifier: NCT01024868     History of Changes
Other Study ID Numbers: TDTSG-1
Study First Received: December 2, 2009
Last Updated: May 3, 2010
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Keywords provided by Herlev Hospital:
Transversus Abdominis Plane Block

Additional relevant MeSH terms:
Ropivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
 Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 19, 2013